QualityStocksNewsBreaks – Zenosense, Inc.’s (ZENO) MIDS Cardiac Device Demonstrates Testing Potential
Through a joint-venture ownership in MIDS Medical Ltd., Zenosense (OTC: ZENO) is developing MIDS Cardiac™, a rapid cardiac diagnostic device. An article discussing the device reads: “In the new testing, the joint venture aimed to magnetically detect assay beads below the 200,000 level in order to support a finding that the technology could be effective in a high-sensitivity troponin test. Previously, the technology had detected down to around 100,000 beads; the new testing brings this down to around the 50,000-bead level, indicating that it is well within the necessary level of detection required for a high-sensitivity assay (http://ibn.fm/mtBiA). The new testing used…